We first mined the TCGA database and found that KRT7-AS expression levels in nine types of cancer were significantly lower than those in matched normal tissues, including lung cancer, breast cancer (Fig. 1A, B), and other seven malignant tumors (Fig. S1A–G). This evidence concerns the gene KRT7 and cancer.